TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+8.07%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$601M
AUM Growth
+$601M
(+5.2%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
2.03%
Top 10 Holdings %
Top 10 Hldgs %
38.16%
Holding
82
New
2
Increased
17
Reduced
39
Closed
3
Top Buys
| 1 |
Brown-Forman Class B
BF.B
|
$10.8M |
| 2 |
Fortive
FTV
|
$5.24M |
| 3 |
Mastercard
MA
|
$1.24M |
| 4 |
CPHD
Cepheid Inc
CPHD
|
$1.16M |
| 5 |
Dentsply Sirona
XRAY
|
$1.08M |
Top Sells
| 1 |
SYT
Syngenta Ag
SYT
|
$6.2M |
| 2 |
Biogen
BIIB
|
$798K |
| 3 |
Hershey
HSY
|
$772K |
| 4 |
Campbell Soup
CPB
|
$575K |
| 5 |
Occidental Petroleum
OXY
|
$232K |
Sector Composition
| 1 | Healthcare | 43.25% |
| 2 | Industrials | 11.78% |
| 3 | Technology | 10.91% |
| 4 | Consumer Staples | 7.78% |
| 5 | Financials | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIF
1
DELISTED
Tiffany & Co.
TIF
| $26.9M | 4.48% |
370,946
+6,455
| +2% | +$469K |
|
2
Cognex
CGNX
$7.38B
| $26.1M | 4.34% |
493,955
-4,365
| -0.9% | -$231K |
|
|
3
Biogen
BIIB
$19.4B
| $25.6M | 4.26% |
81,910
-2,550
| -3% | -$798K |
|
4
Johnson & Johnson
JNJ
$427B
| $24.4M | 4.06% |
206,906
-1,510
| -0.7% | -$178K |
|
5
DexCom
DXCM
$29.5B
| $23.8M | 3.96% |
271,520
-105
| -0% | -$9.2K |
|
|
6
Brown-Forman Class B
BF.B
$14.2B
| $21.8M | 3.62% |
458,747
+228,351
| +99% | +$10.8M |
|
7
Analog Devices
ADI
$124B
| $21.5M | 3.57% |
333,151
-200
| -0.1% | -$12.9K |
|
8
Neogen
NEOG
$1.25B
| $20.4M | 3.39% |
363,924
+105
| +0% | +$5.87K |
|
9
Danaher
DHR
$147B
| $19.5M | 3.24% |
248,541
+1,945
| +0.8% | +$152K |
|
10
Idexx Laboratories
IDXX
$51.8B
| $19.5M | 3.24% |
172,635
-1,970
| -1% | -$222K |
|
11
Honeywell
HON
$139B
| $19.1M | 3.18% |
163,842
-260
| -0.2% | -$30.3K |
|
|
RTN
12
DELISTED
Raytheon Company
RTN
| $18.7M | 3.11% |
137,582
-1,259
| -0.9% | -$171K |
|
13
Henry Schein
HSIC
$8.44B
| $16.5M | 2.75% |
101,434
+2,975
| +3% | +$485K |
|
14
Novo Nordisk
NVO
$251B
| $16.3M | 2.7% |
390,970
+8,595
| +2% | +$357K |
|
|
15
Mastercard
MA
$538B
| $15.8M | 2.62% |
154,925
+12,175
| +9% | +$1.24M |
|
16
Schlumberger
SLB
$55B
| $15.1M | 2.51% |
192,257
-15
| -0% | -$1.18K |
|
17
Amgen
AMGN
$155B
| $14.2M | 2.36% |
85,217
-350
| -0.4% | -$58.4K |
|
18
W.W. Grainger
GWW
$48.5B
| $14.1M | 2.34% |
62,592
-977
| -2% | -$220K |
|
19
Insulet
PODD
$23.9B
| $12.9M | 2.15% |
316,225
+15,590
| +5% | +$638K |
|
|
CPHD
20
DELISTED
Cepheid Inc
CPHD
| $12.1M | 2.02% |
230,105
+21,950
| +11% | +$1.16M |
|
21
Ross Stores
ROST
$48.1B
| $11M | 1.83% |
170,990
-460
| -0.3% | -$29.6K |
|
|
ABMD
22
DELISTED
Abiomed Inc
ABMD
| $10.6M | 1.76% |
82,425
-375
| -0.5% | -$48.2K |
|
23
Williams-Sonoma
WSM
$23.1B
| $10.5M | 1.75% |
206,075
+7,475
| +4% | +$382K |
|
24
Inogen
INGN
$216M
| $10.4M | 1.73% |
174,150
-400
| -0.2% | -$24K |
|
|
25
Dentsply Sirona
XRAY
$2.85B
| $10.2M | 1.7% |
171,896
+18,127
| +12% | +$1.08M |
|